# Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

> **NCT00309894** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 49 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** sargramostim
- **DRUG:** ketoconazole
- **DRUG:** therapeutic hydrocortisone

## Key facts

- **NCT ID:** NCT00309894
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309894, "Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00309894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*